Quick Links

View Map

Swissmedic approves Moderna bivalent COVID-19 booster vaccine

Switzerland // 29 August, 2022

Swissmedic, the Swiss Agency for Therapeutic Products, has temporarily authorised Moderna's bivalent booster shot that targets the Omicron variant BA.1. The Federal Commission for Vaccination (FCV) and the Federal Office of Public Health (FOPH) are working to create the recommendations for use for the booster shot. Compared to the original Moderna COVID-19 vaccine, new bivalent booster has shown in clinical trials to provide a stronger response against the Omicron variants BA.1 and BA.4/.5.

LATEST NEWS

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. …
Webinars

Pandemic Information Webinars
(Available to Pandemic Subscribers only)
Register for upcoming events
View/Download previous webinars

MERS CoV

MERS-CoV Information

MERS-CoV FAQs